Back to UBS Group AG UBS Group AG

SDEVSDEV
2 quarters

Position history for UBS Group AGUBS Group AG's holdings in NOVABAY PHARMACEUTICALS INC COM SHS

UBS Group AG holds 205 shares of SDEV (NOVABAY PHARMACEUTICALS INC COM SHS), worth $215 as of 2026-Q2. The position was increased (+6733.3% shares).

Current Value

$215

Current Shares

205

Total Value Change

+$211

Total Shares Change

+202

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
205
+6733.3%
$2150.0%$1.05
12
2026-Q1
New
3
-
$40.0%$1.49
17

Other major holders of SDEV: BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used